FDA says no injuries reported, as manufacturer voluntarily recalls GlucoPro Insulin Syringes
MONDAY, Jan. 25 (HealthDay News) -- According to a Jan. 21 press release issued by the U.S. Food and Drug Administration, the Nipro Medical Corporation has voluntarily recalled all of its GlucoPro Insulin Syringes because of a defect that may cause the needle to detach from the syringe, resulting in its being stuck in the insulin vial, pushed back into the syringe, or lodged in the patient's skin.
The recall includes all GlucoPro Insulin Syringe product codes and lot numbers with expiration dates before Nov. 1, 2011, distributed throughout the United States and Puerto Rico. The recall does not include the GlucoPro syringe that is used with the Amigo Insulin pump.
The FDA said that no injuries have been reported from the defective syringes to date, and that the company is in the process of notifying its distributors and customers and arranging for the return of all recalled products.
"Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax," according to the press release.
FDA MedWatch Adverse Event Reporting